Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 303929, 11 pages
http://dx.doi.org/10.1155/2014/303929
Research Article

High Level of Tregs Is a Positive Prognostic Marker in Patients with HPV-Positive Oral and Oropharyngeal Squamous Cell Carcinomas

1Department of Otorhinolaryngology and Head and Neck Surgery, 1st Faculty of Medicine, Charles University in Prague, University Hospital Motol, 150 06 Prague, Czech Republic
2Department of Experimental Virology, Institute of Hematology and Blood Transfusion, 128 20 Prague, Czech Republic
3Institute of Microbiology Academy of Sciences of the Czech Republic, Public Research Institution, 142 20 Prague, Czech Republic
4Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague, University Hospital Motol, 150 06 Prague, Czech Republic
5Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University in Prague, 150 06 Prague, Czech Republic

Received 24 February 2014; Accepted 25 March 2014; Published 23 April 2014

Academic Editor: Jan Plzák

Copyright © 2014 E. Lukesova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Warnakulasuriya, “Global epidemiology of oral and oropharyngeal cancer,” Oral Oncology, vol. 45, no. 4-5, pp. 309–316, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Zivile, D. Janina, M. Irina, C. Saulius, S. Raisa, and Z. Aliaksandr, “Prevalence of human papillomaviruses in patients with head and neck squamous cell carcinoma in Lithuania and Belarus,” Journal of Medical Virology, vol. 86, no. 3, pp. 531–535, 2014. View at Publisher · View at Google Scholar
  3. L. Hammarstedt, D. Lindquist, H. Dahlstrand et al., “Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer,” International Journal of Cancer, vol. 119, no. 11, pp. 2620–2623, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. E. M. Genden, I. M. Sambur, J. R. de Almeida, M. Posner, A. Rinaldo, J. P. Rodrigo et al., “Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should know,” European Archives of Oto-Rhino-Laryngology, vol. 270, no. 2, pp. 405–416, 2013. View at Publisher · View at Google Scholar
  5. A. Näsman, P. Attner, L. Hammarstedt et al., “Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?” International Journal of Cancer, vol. 125, no. 2, pp. 362–366, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. K. Chaturvedi, E. A. Engels, W. F. Anderson, and M. L. Gillison, “Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States,” Journal of Clinical Oncology, vol. 26, no. 4, pp. 612–619, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. E. M. Smith, J. M. Ritchie, K. F. Summersgill et al., “Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers,” International Journal of Cancer, vol. 108, no. 5, pp. 766–772, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Sivasithamparam, C. A. Visk, E. E. Cohen, and A. C. King, “Modifiable risk behaviors in patients with head and neck cancer,” Cancer, vol. 119, no. 13, pp. 2419–2426, 2013. View at Publisher · View at Google Scholar
  9. E. Rotnaglova, R. Tachezy, M. Salakova, B. Prochazka, E. Kosl'abova, E. Vesela et al., “HPV involvement in tonsillar cancer: prognostic significance and clinically relevant markers,” International Journal of Cancer Journal International Du Cancer, vol. 129, pp. 101–110, 2011. View at Google Scholar
  10. P. Attner, J. Du, A. Näsman et al., “Human papillomavirus and survival in patients with base of tongue cancer,” International Journal of Cancer, vol. 128, no. 12, pp. 2892–2897, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Plummer, M. Schiffman, P. E. Castle, D. Maucort-Boulch, and C. M. Wheeler, “A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion,” Journal of Infectious Diseases, vol. 195, no. 11, pp. 1582–1589, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Saussez, A. Duray, S. Demoulin, P. Hubert, and P. Delvenne, “Immune suppression in head and neck cancers: a review,” Clinical and Developmental Immunology, vol. 2010, Article ID 701657, 15 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. T. K. Hoffmann, G. Dworacki, T. Tsukihiro et al., “Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance,” Clinical Cancer Research, vol. 8, no. 8, pp. 2553–2562, 2002. View at Google Scholar · View at Scopus
  14. T. L. Whiteside, “Immunobiology of head and neck cancer,” Cancer and Metastasis Reviews, vol. 24, no. 1, pp. 95–105, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. V. M. Renoux, B. Bisig, I. Langers et al., “Human papillomavirus entry into NK cells requires CD16 expression and triggers cytotoxic activity and cytokine secretion,” European Journal of Immunology, vol. 41, no. 11, pp. 3240–3252, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Textor, M. Dürst, L. Jansen et al., “Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer,” International Journal of Cancer, vol. 123, no. 10, pp. 2343–2353, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Wulff, R. Pries, K. Börngen, T. Trenkle, and B. Wollenberg, “Decreased levels of circulating regulatory NK cells in patients with head and neck cancer throughout all tumor stages,” Anticancer Research, vol. 29, no. 8, pp. 3053–3057, 2009. View at Google Scholar · View at Scopus
  18. W. P. Accomando, J. K. Wiencke, E. A. Houseman, R. A. Butler, S. Zheng, H. H. Nelson et al., “Decreased NK cells in patients with head and neck cancer determined in archival DNA,” Clinical Cancer Research, vol. 18, pp. 6147–6154, 2012. View at Google Scholar
  19. J. W. Molling, J. A. E. Langius, J. A. Langendijk et al., “Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma,” Journal of Clinical Oncology, vol. 25, no. 7, pp. 862–868, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. U. K. Liyanage, T. T. Moore, H.-G. Joo et al., “Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma,” Journal of Immunology, vol. 169, no. 5, pp. 2756–2761, 2002. View at Google Scholar · View at Scopus
  21. P. Salama, M. Phillips, F. Grieu et al., “Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer,” Journal of Clinical Oncology, vol. 27, no. 2, pp. 186–192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Karagoz, O. Bilgi, M. Gümüs et al., “CD8+CD28 cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients,” Medical Oncology, vol. 27, no. 1, pp. 29–33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Fu, Z. Zhang, L. Zhou, Z. Qi, S. Xing, J. Lv et al., “Impairment of CD4(+) cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma,” Hepatology, vol. 58, no. 1, pp. 139–149, 2013. View at Publisher · View at Google Scholar
  24. A. Ladányi, B. Somlai, K. Gilde, Z. Fejös, I. Gaudi, and J. Tímár, “T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma,” Clinical Cancer Research, vol. 10, no. 2, pp. 521–530, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. R. K. Bhairavabhotla, V. Verma, H. Tongaonkar, S. Shastri, K. Dinshaw, and S. Chiplunkar, “Role of IL-10 in immune suppression in cervical cancer,” Indian Journal of Biochemistry and Biophysics, vol. 44, no. 5, pp. 350–356, 2007. View at Google Scholar · View at Scopus
  26. K.-M. Lau, S. H. Cheng, K. W. Lo et al., “Increase in circulating Foxp3+ CD4+ CD25high regulatory T cells in nasopharyngeal carcinoma patients,” British Journal of Cancer, vol. 96, no. 4, pp. 617–622, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Schaefer, G. G. Kim, A. Albers, K. Hoermann, E. N. Myers, and T. L. Whiteside, “Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer,” British Journal of Cancer, vol. 92, no. 5, pp. 913–920, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Strauss, C. Bergmann, W. Gooding, J. T. Johnson, and T. L. Whiteside, “The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck,” Clinical Cancer Research, vol. 13, no. 21, pp. 6301–6311, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Boucek, T. Mrkvan, M. Chovanec et al., “Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck,” Journal of Cellular and Molecular Medicine, vol. 14, no. 1-2, pp. 426–433, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Badoual, S. Hans, J. Rodriguez et al., “Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers,” Clinical Cancer Research, vol. 12, no. 2, pp. 465–472, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. Y.-L. Zhang, J. Li, H.-Y. Mo et al., “Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways,” Molecular Cancer, vol. 9, article 4, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Wamsom, E. Light, D. Thomas et al., “Infiltrating lymphocytes and human papillomavirus-16-associated oropharyngeal cancer,” Laryngoscope, vol. 122, no. 1, pp. 121–127, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Näsman, M. Romanitan, C. Nordfors, N. Grun, H. Johansson, L. Hammarstedt et al., “Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer,” PloS ONE, vol. 7, Article ID e38711, 2012. View at Google Scholar
  34. H. J. Aarstad, J.-H. Heimdal, B. Klementsen, J. Olofsson, and E. Ulvestad, “Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis,” Acta Oto-Laryngologica, vol. 126, no. 12, pp. 1326–1333, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. V. L. Green, A. Michno, N. D. Stafford, and J. Greenman, “Increased prevalence of tumour infiltrating immune cells in oropharyngeal tumours in comparison to other subsites: relationship to peripheral immunity,” Cancer Immunology, Immunotherapy, vol. 62, pp. 863–873, 2013. View at Google Scholar
  36. E. Koslabova, E. Hamsikova, M. Salakova, J. Klozar, E. Foltynova, E. Salkova et al., “Markers of HPV infection and survival in patients with head and neck tumours,” International Journal of Cancer, vol. 133, no. 8, pp. 1832–1839, 2013. View at Google Scholar
  37. J. Klozar, V. Kratochvil, M. Salakova et al., “HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer,” European Archives of Oto-Rhino-Laryngology, vol. 265, no. 1, pp. S75–S82, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Tachezy, J. Klozar, M. Saláková et al., “HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic,” Oral Diseases, vol. 11, no. 3, pp. 181–185, 2005. View at Google Scholar · View at Scopus
  39. A. J. C. van den Brule, R. Pol, N. Fransen-Daalmeijer, L. M. Schouls, C. J. L. M. Meijer, and P. J. F. Snijders, “GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes,” Journal of Clinical Microbiology, vol. 40, no. 3, pp. 779–787, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. P. E. Gravitt, C. Peyton, C. Wheeler, R. Apple, R. Higuchi, and K. V. Shah, “Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays,” Journal of Virological Methods, vol. 112, no. 1-2, pp. 23–33, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. S. J. Smeets, A. T. Hesselink, E.-J. M. Speel et al., “A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen,” International Journal of Cancer, vol. 121, no. 11, pp. 2465–2472, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Raghavan and M. Quiding-Jädierbrink, “Regulatory T cells in gastrointestinal tumors,” Expert Review of Gastroenterology and Hepatology, vol. 5, no. 4, pp. 489–501, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Ladoire, F. Martin, and F. Ghiringhelli, “Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer,” Cancer Immunology, Immunotherapy, vol. 60, no. 7, pp. 909–918, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. X. Ke, J. Wang, J. Li, I. H. Chen, H. Wang, and X.-F. Yang, “Roles of CD4+CD25high FOXP3+ Tregs in lymphomas and tumors are complex,” Frontiers in Bioscience, vol. 13, no. 10, pp. 3986–4001, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Álvaro, M. Lejeune, M. T. Salvadó et al., “Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells,” Clinical Cancer Research, vol. 11, no. 4, pp. 1467–1473, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Roncador, P. J. Brown, L. Maestre et al., “Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level,” European Journal of Immunology, vol. 35, no. 6, pp. 1681–1691, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda, “Pillars article: immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995,” Journal of Immunology, vol. 186, pp. 3808–3821, 2011. View at Google Scholar
  48. E. M. Smith, L. M. Rubenstein, T. H. Haugen, M. Pawlita, and L. P. Turek, “Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease,” Journal of Oncology, vol. 2012, Article ID 571862, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Hoffmann, S. Tribius, E. S. Quabius et al., “HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer—how valid is p16INK4A as surrogate marker?” Cancer Letters, vol. 323, no. 1, pp. 88–96, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. E. Ames and W. J. Murphy, “Advantages and clinical applications of natural killer cells in cancer immunotherapy,” Cancer Immunology, Immunotherapy, vol. 63, no. 1, pp. 21–28, 2014. View at Google Scholar